Vena cava filter study for people with blood clots in the veins or lungs
Follows adults with a Celect Platinum filter to check its safety over time.
Key facts
- Who runs it
- Cook Research Incorporated
- Where
- Los Angeles, United StatesSee the siteAlso in 2 other countries, 6 sites
- Trial code
- Registry title
- Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
- Status
- Recruiting
- People taking part
- 82 people, planned
- Started
- 2 Jun 2025
- Expected to end
- Dec 2031
- Type of study
- Observational
- Treatments tested
- Celect Platinum Vena Cava Filter
- Record updated
- 12 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have a procedure to place a Celect Platinum Vena Cava Filter. This is a filter put in a large vein to catch blood clots. The study collects data on how the filter works over up to 5 years.
- Age
- 18 Years and older
- Sex
- All sexes
- Earlier treatment
- People who took part in the Cook MDR-2126 study before cannot join.
Main reasons for not taking part
- The patient or their legal representative objects to the collection and use of the patient's data
- The patient or their legal representative is not willing to sign the consent form
- Took part in the Cook MDR-2126 study before
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- A patient dataset is deemed suitable for inclusion if the patient has a procedure where a Celect Platinum Vena Cava Filter is placed
- Subject has not previously participated in the Cook MDR-2126 study
Who cannot take part
- Patients will be excluded from enrollment if the patient or his/her legally authorized representative objects to collection and processing of his/her data or is not willing to sign the Informed Consent
Where in United States
Also in 2 other countries, 6 sites
- Cedars-Sinai Medical CenterLos Angeles, United StatesContact: Sabina AndersenTaking people
About the trial
What the trial wants to find out
This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and continued acceptability of the benefit:risk ratio. Additionally, the study intends to evaluate longer-term (i.e., up to 5 years) outcome data while the filter is indwelling.
The group in the trial
- Patients indicated for the placement of a Celect Platinum Vena Cava Filter
Treatment: Celect Platinum Vena Cava Filter
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Post-Market Celect Platinum Vena Cava Filter and Günther Tulip Retrieval Set Study
- Plain-language title
- Vena cava filter study for people with blood clots in the veins or lungsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 12 November 2026